Literature DB >> 3881837

Clinical and experimental studies with cyclosporine in renal transplantation.

B D Kahan, C T van Buren, S M Flechner, M Jarowenko, T Yasumura, A J Rogers, N Yoshimura, S LeGrue, D Drath, R H Kerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3881837

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  8 in total

Review 1.  Cardiac transplantation. Selection, immunosuppression, and survival.

Authors:  L W Stevenson; H Laks; P I Terasaki; B D Kahan; D C Drinkwater
Journal:  West J Med       Date:  1988-11

2.  Gastrointestinal complications after cardiac transplantation. Potential benefit of early diagnoses and prompt surgical intervention.

Authors:  J K Kirklin; A Holm; J S Aldrete; C White; R C Bourge
Journal:  Ann Surg       Date:  1990-05       Impact factor: 12.969

Review 3.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

4.  Gastrointestinal perforations in renal transplant recipients immunosuppressed with cyclosporin.

Authors:  P Rigotti; C T Van Buren; W D Payne; C Peters; B D Kahan
Journal:  World J Surg       Date:  1986-02       Impact factor: 3.352

Review 5.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

6.  Experience of a Canadian multi-organ transplant service.

Authors:  D Grant; C Stiller; J Duff; N McKenzie; W Wall; P Keown; C Ghent; W Kostuk; J Kutt; J Chin
Journal:  CMAJ       Date:  1986-08-01       Impact factor: 8.262

7.  Value of sonography for follow-up examination after allogenic kidney transplantation.

Authors:  A el Mouaaouy; J Mellert; T Wetzel; U T Hopt
Journal:  Surg Endosc       Date:  1991       Impact factor: 4.584

8.  Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine.

Authors:  S A Gruber; S Venkataram; D M Canafax; R J Cipolle; L Bowers; D Elsberry; M McGuiggan; P E Hynes; J A Ritz; F H Gould
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.